Platinum Press Inc. (PPI), a provider of printed packaging solutions, has completed a $15 million expansion and ...

The U.S. Food and Drug Administration (FDA) has accepted Sentynl Therapeutics Inc.’s New Drug Application (NDA) for CUTX-101 ...

“Today marks a significant milestone in Halia’s journey,” said Dr. David J. Bearss, President & CEO of Halia Therapeutics.

Adheres to requirements, including 21 CFR Part 820 and Good Manufacturing Practices.

Nitroxoline has not been approved by the FDA, and its use is therefore considered investigational. FLA patients will receive ...

WuXi Biologics plans to sell its vaccine facility in Dundalk, Ireland to Merck & Co. for approximately $500 million. This ...

Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle ...

LPOXY Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on innovative therapies for infectious disease ...